Lilly Asia Venture Invests $15M In MabSpace Biosciences’ Series A Round

This Data Is Locked!

This area is available only to Subscribers.

Suzhou city, Jiangsu province-based MabSpace Biosciences, a start-up focused on developing antibody therapeutics for cancer treatment, has completed US$15 million series A round of financing... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?